Aurobindo Pharma USA arm, Evive Biotech bags USFDA nod for Ryzneuta for Chemotherapy-Induced Neutropenia Ruchika Sharma22 Nov 2023 12:30 PM ISTRyzneuta is a novel long-acting Granulocyte colonystimulating factor (G-CSF), which can stimulate the proliferation, differentiation, and release of...
Apixaban fails to check VTE among children with lymphocytic leukemia Niveditha Subramani22 Nov 2023 3:00 AM ISTAcute lymphocytic leukemia is the most common type of cancer in children, and treatments result in a good chance for a cure. However complications are...
FAPI-PET imaging better diagnostic option for Pancreatic Adenocarcinoma Niveditha Subramani22 Nov 2023 2:00 AM ISTPancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with extremely poor survival rates. It is well known that because of late detection, PDAC...
Is ultrasound-guided vacuum-assisted excision reliable for removing small breast cancers? Dr. Kamal Kant Kohli19 Nov 2023 7:00 PM ISTFinland: A recent study published in the European Journal of Radiology has suggested that ultrasound-guided vacuum-assisted excision (VAE) is not a...
AstraZeneca Imfinzi plus chemotherapy approved in China for locally advanced or metastatic biliary tract cancer Ruchika Sharma19 Nov 2023 11:45 AM ISTImfinzi (durvalumab) is a human monoclonal antibody that binds to the PD-L1 protein and blocks the interaction of PD-L1 with the PD-1 and CD80...
Roche subcutaneous injection of Tecentriq recommended by EU CHMP for multiple cancer types Ruchika Sharma19 Nov 2023 10:00 AM ISTBasel: Roche has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of...
Bayer recalls one lot of cancer drug Vitrakvi in US over microbial contamination Ruchika Sharma18 Nov 2023 4:30 PM ISTCustomers who have the recalled lot should immediately stop use of the drug and contact their physician or healthcare provider, the company said.
Truqap plus Faslodex approved in US for advanced HR-positive breast cancer: AstraZeneca Ruchika Sharma18 Nov 2023 2:14 PM ISTCambridge: AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in the US for the treatment of adult...
USFDA nod to Pfizer, Astellas Pharma Xtandi for early prostate cancar Ruchika Sharma17 Nov 2023 12:30 PM ISTTokyo: Pfizer Inc. and Astellas Pharma Inc. have announced that the companies have received approval from the U.S. Food and Drug Administration...
AstraZeneca breast cancer drug combination gets USFDA okay Ruchika Sharma17 Nov 2023 11:37 AM ISTTruqap belongs to a class of drugs known as AKT inhibitors and works by targeting the AKT1 gene mutation, which is responsible for growth and...
Diabetes drug for prostate cancer? Columbia study provides clarity Dr. Kamal Kant Kohli16 Nov 2023 8:00 PM ISTIn the years since a 2005 study found that diabetes patients taking metformin had lower rates of cancer, oncologists have been excited by the prospect...
USFDA nod to Bristol Myers Squibb Augtyro for lung cancer Ruchika Sharma16 Nov 2023 5:30 PM ISTAugtyro is designed to minimize interactions that can lead to certain forms of treatment resistance in ROS1-positive metastatic NSCLC patients.
